The Cooper Companies, Inc.
COO
株式のランク
#1884
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
株価
$59.03
最終同期: 2026-10-20
時価総額
$11.23B
変化（1日）
1.50%
変化（1年）
-21.29%
国
US
取引 The Cooper Companies, Inc. (COO)
カテゴリー
Healthcare
The Cooper Companies, Inc.（COO）の収益
Jul 2026 時点の収益 TTM: $4.24B
The Cooper Companies, Inc. の最新の財務報告によると、現在の収益 (TTM) は $4.24B です。2024 年には $3.90B の収益があり、これは 2023 年の $3.59B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
The Cooper Companies, Inc. の収益履歴（2000 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $4.24B | 3.53% |
| 2025 | $4.09B | 5.06% |
| 2024 | $3.90B | 8.41% |
| 2023 | $3.59B | 8.61% |
| 2022 | $3.31B | 13.20% |
| 2021 | $2.92B | 20.22% |
| 2020 | $2.43B | -8.39% |
| 2019 | $2.65B | 4.76% |
| 2018 | $2.53B | 18.41% |
| 2017 | $2.14B | 8.75% |
| 2016 | $1.97B | 9.45% |
| 2015 | $1.80B | 4.62% |
| 2014 | $1.72B | 8.19% |
| 2013 | $1.59B | 9.87% |
| 2012 | $1.45B | 8.59% |
| 2011 | $1.33B | 14.87% |
| 2010 | $1.16B | 7.23% |
| 2009 | $1.08B | 1.62% |
| 2008 | $1.06B | 11.84% |
| 2007 | $950.64M | 10.67% |
| 2006 | $858.96M | 6.49% |
| 2005 | $806.62M | 64.56% |
| 2004 | $490.18M | 19.04% |
| 2003 | $411.79M | 30.60% |
| 2002 | $315.31M | 34.42% |
| 2001 | $234.57M | 18.88% |
| 2000 | $197.32M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $11.03B | 160.43% |
US
|
|
| $34.74B | 719.84% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 391.83% |
US
|
|
| - | - |
CH
|
